Huagai Capital

Synaire engaged in the research and development, production and other related businesses of home ventilators, oxygen concentrators, and non-invasive ventilators.

Shanghai Bioshine Biotechnology Co. is a bitotech company offering biopharmaceutical, medical research, and in vitro diagnostic solutions.

ViGeneron GmbH is a biotechnology company specializing in the development of gene therapies aimed at treating ophthalmic diseases, particularly those with significant unmet medical needs. Founded in 2017 and based in Starnberg, Germany, ViGeneron leverages two proprietary adeno-associated virus (AAV) technology platforms: the vgAAV gene therapy vector platform, which enhances transduction efficiency and allows for less invasive intravitreal treatment, and the REVeRT platform, designed to address diseases caused by mutations in large genes. The company is committed to advancing innovative therapies for retinal disorders and collaborates with leading biopharmaceutical companies to expand its impact in other disease areas. ViGeneron’s experienced team brings extensive expertise in AAV vector technology and clinical ophthalmic gene therapy programs.

Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturing designs and supporting embedded programs.

Amazinc is a zinc battery R&D and production company that specializes in zinc battery development and manufacture.Amazinc offering a systematic design of leading zinc-based battery solutions, including energy storage mechanisms, battery materials, and structural design.

Baijun Biotechnology is a major player in the field of biopharmaceutical R&D services due to its one-stop biotechnology R&D service platform, strong R&D skills, and extensive industry experience.

Ai Sensing Technology is a national high-tech enterprise that focus on the research, development and production of bionic olfactory chips.

Micro Interventional is a company that develops active interventional innovative medical devices. It emphasizes the development of novel medical devices with a product strategy centered on the precise interventional treatment of coronary heart disease and peripheral arterial disease.

Cybernetics is a producer of digital energy solutions and products based on electrical measuring technology.

Utarn Technology is a technology company specializing in pulsed neural network technology for the commercial application of brain-like artificial intelligence. The company has developed an intelligent robot named "Zhi Zunbao," which assists users in decision-making by simulating the operational modes of the biological brain. This innovation aims to enhance efficiency and reduce costs for consumers. Utarn Technology focuses on key areas such as big entertainment and autonomous driving, introducing concepts like Game Mate and Car Mate series robots to further integrate its technology into everyday applications.

Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.

Bowang Pharmaceutical is an RNAi drug research and development platform focused on siRNA drug development.

Leo Summit is positioned as a provider of life science laboratory automation solutions. It provides reliable and flexible solutions for the biomedical industry, driven by the demand for automated intelligent technology in clinical medicine and drug R&D industries, and relies on artificial intelligence and motion control technology. Provide systematic intelligent products and solutions for R&D firms, AI pharmaceuticals, and CRO firms in the fields of new medications, synthetic biology, and single-cell sequencing.

Leaf Biotech is a company that specializes in research and development, production, and sales of green chemical-related materials and intermediates. It focuses on creating biomass resources and developing bio-based polyester materials, particularly Polyethylene Furanoate (PEF) and its core monomer, furandicarboxylic acid (FDCA). The company is dedicated to advancing sustainable solutions by producing important intermediates for green drugs and healthcare products, thereby contributing to a more sustainable environment.

Dingzhi Biotech specialized in immunology and animal vaccine development. It focuses on innovative and large varieties in the research of covers poultry, livestock, and pets.

Chromai is a company specializing in high-performance intelligent liquid chromatography and medical diagnostic solutions. It focuses on independent innovation and aims to contribute to the revitalization of the national industry. Chromai develops advanced medical molecular diagnostics and testing technologies that streamline the diagnostic process. By leveraging a combination of artificial intelligence, Big Data, and Internet of Things (IoT) technologies alongside leading analysis and detection methods, the company is dedicated to enhancing the fields of health in vitro diagnostics (IVD), environmental protection, and scientific instruments. This commitment enables medical users to achieve simplified and efficient diagnostic and testing analyses.

Sangon Biotech Co. is a biotechnology company founded in 2003 as a Sino-foreign joint venture, specializing in the research and development of chemical synthesis of DNA. Over the years, Sangon has established itself as a key player in the global biotechnology market, known for its expertise in DNA synthesis, sequencing, and gene synthesis. The company has invested significantly in its infrastructure, including a manufacturing and industrial base in Songjiang Industrial Park. Sangon offers a wide range of products and services, including molecular biology kits, biochemicals, synthetic genes, oligos, peptide synthesis, enzymes, and laboratory consumables. By providing affordable life science research tools and services, Sangon supports researchers in advancing basic research and product development in the life sciences field.

Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies.

Libaote Food is a manufacturing company specializing in the supply of fresh and frozen meat to restaurants and retail shops. It operates a one-stop mobile application that facilitates the ordering process for catering businesses, streamlining access to high-quality protein products. Libaote Food boasts its own overseas supplier resources, independent storage facilities, and a dedicated procurement operation, ensuring efficient supply chain management. The company also emphasizes quality control through its inspection teams, which maintain high standards for the meat products offered to its clients.

Chengdu Qitan Technology Co., Ltd. specializes in the development and manufacture of advanced gene sequencing instruments utilizing nanopore technology. Founded in 2016 and based in Chengdu, China, the company offers a fourth generation gene sequencer that enables single-molecule sequencing with long read lengths and real-time output. This innovative technology is designed to serve various sectors, including biopharmaceuticals, healthcare, and agriculture, facilitating applications such as immunophenotyping, pathogen detection, analysis of intestinal flora, and tumor genome detection. Qitan Tech's solutions are notable for their cost-effectiveness and simplicity, as they do not require complicated library preparation, thus enhancing the accessibility of gene sequencing for cutting-edge biological research and clinical diagnostics.

Leo Summit is positioned as a provider of life science laboratory automation solutions. It provides reliable and flexible solutions for the biomedical industry, driven by the demand for automated intelligent technology in clinical medicine and drug R&D industries, and relies on artificial intelligence and motion control technology. Provide systematic intelligent products and solutions for R&D firms, AI pharmaceuticals, and CRO firms in the fields of new medications, synthetic biology, and single-cell sequencing.

Carmine Therapeutics, established in 2019 and headquartered in Singapore, specializes in gene therapy. It produces extracellular vesicles from red blood cells as a non-viral, re-dosable gene delivery vehicle, addressing challenges posed by traditional viral-based therapies such as immunogenicity, limited transgene capacity, and manufacturing complexities. The company focuses on developing next-generation gene therapies for hematology, oncology, and immunology.

Ubrigene is driven by the advancement of gene and cell therapy technologies through research and development represented by AAV vectors. It can provide a comprehensive solution for gene therapy industrialization.

Deepway is a manufacturer of smart vehicles focused on providing intelligent driving solutions for the truck freight market. The company specializes in heavy-duty trucks characterized by low wind resistance bodies and advanced intelligent driving capabilities. Its vehicles feature a distributed drive system with a modular design, which operates on a unified hydrogen and electricity platform. This innovative approach allows the logistics industry to leverage smart freight systems, enhancing efficiency and sustainability in transportation.

MobiDrop Biotech specializes in developing microfluidic technologies tailored for life sciences and precision medicine. The company is dedicated to enhancing molecular diagnostics and life science research through innovative platforms that improve the accuracy and efficiency of diagnosis and testing. MobiDrop produces integrated machine platforms, microfluidic detection chips, extensive assays, and user-friendly software specifically designed for digital droplet PCR and single-cell multi-omic applications. Its products find applications in molecular diagnostics, cancer screening, and drug research and development, providing groundbreaking solutions that advance the quality of healthcare and research capabilities.

Huojianpai is a commercial aerospace company providing earth-moon space economy and future-oriented deep space exploration.

Kingstar is a fintech service provider that specializes in delivering comprehensive solutions for large financial institutions. The company focuses on the digital transformation of the capital markets, offering a range of services including trading management systems, risk management solutions, and educational software. Kingstar's expertise encompasses distributed architecture transaction support and operational systems specifically tailored for the securities industry. Additionally, the firm provides risk and internal control management systems that address the needs of the financial securities sector throughout various stages of operation. By concentrating on areas such as capital markets and enterprise risk management, Kingstar aims to enhance efficiency for organizations, private sectors, and government agencies.

Shanghai Perfect Match Flexible Supply Chain Service is an operator for catering and retail fresh food supply chains. Their services include a central kitchen industrial park, fresh delivery, low-temperature storage, intercity transport, and cold chain transportation.

Reistone Biopharma is a clinical stage biopharmaceutical company dedicated to the rapid development of innovative medicines aimed at treating autoimmune and inflammatory diseases with significant unmet medical needs. The company is particularly focused on developing therapies for inflammatory bowel diseases, including ulcerative colitis and Crohn's disease, as well as dermatological conditions such as atopic dermatitis. Reistone Biopharma engages in global collaborations to enhance its research and development efforts, striving to deliver effective treatment options for patients suffering from these challenging health conditions.

Clounix is a software startup specializing in high-performance network chips and solutions. The company focuses on developing application-specific integrated circuits (ASICs) designed for cloud networking, which enhance high-speed packet switching capabilities. By emphasizing low latency and ultra-high-speed principles, Clounix supports super-internet companies, medium and large enterprises, and network operators in building next-generation networks and data centers. Their efforts include creating both the underlying hardware and customized software that align with cloud-native environments, thereby facilitating the advancement of cutting-edge networking technology.

Singlomics is a biotechnology company that leverages single-cell sequencing technology to develop innovative antibody drugs aimed at treating infectious diseases and cancers. The company focuses on the discovery and development of neutralizing antibodies, including DXP593 and DXP604, which serve as potential therapeutic solutions against COVID-19. By utilizing advanced sequencing techniques, Singlomics aims to enhance the efficacy of antibody treatments and address significant health challenges in infectious diseases and oncology.

Chuanxin Biotech is an RNA drug research and development service provider.

GenFleet Therapeutics, established in 2017 and headquartered in Shanghai, China, is a biotechnology company focused on cancer research and development. It specializes in creating therapeutic molecules, including signal transduction regulators, tumor microenvironment modulators, and transcription factors, to target various cancer systems. The company aims to develop innovative molecular-level pharmaceuticals and antibody drugs that can effectively stimulate the body's immune response against tumors. GenFleet serves both domestic and international clients.

MindRank is an artificial intelligence (AI)-driven drug discovery company focused on accelerating the development of small molecule medicines that offer unique clinical benefits. Utilizing its proprietary AI platforms, including PharmKG, Molecule Dance, and Molecule Pro, MindRank enhances the drug discovery process by providing rapid recommendations for cost-effective synthesis routes and effective drug design solutions. The company's innovative approach aims to streamline the pathway from compound identification to therapeutic application, ultimately improving healthcare outcomes through advanced pharmaceutical development.

Beijing Sudo Technology specializes in privacy protection services through comprehensive engineering solutions. The company has developed an encryption platform that enables secure data collaboration by utilizing advanced technologies such as cryptography, federated learning, and robust data engineering. This platform facilitates multi-party data collaboration while ensuring that original data remains untransmitted, allowing clients to work together securely and privately.

Datong Insurance is a professional third-party financial insurance service organization. Datong’s subsidiaries include Datong Insurance Sales Service Co., Ltd., Beijing Datong Insurance Brokers Co., Ltd., among which Datong Insurance Sales Service Co., Ltd. is approved by the China Insurance Regulatory Commission. The first national insurance professional sales and service organization approved to be established. At present, the Datong service network has covered more than 20 provinces and municipalities across the country.

NeuraMatrix is an innovative developer of brain-computer interface technology, specializing in advanced neural interfaces that facilitate communication between humans and computers. The company's comprehensive approach includes both hardware and software solutions, aiming to enhance human interaction with technology and advance research in brain science and neurological diseases. NeuraMatrix focuses on improving diagnosis, treatment, and drug development for neurological conditions while leveraging the significant commercial potential of its brain-computer interface technologies. Recently, the company secured significant funding to support research and development efforts, including the update of R&D equipment, mass production of chips, product iterations, and market promotion. Through its pioneering efforts, NeuraMatrix is positioned to influence the future of neuroscience research and its practical applications.

H.Extract is a company focused on research and development, promotion, and sales of pharmaceutical enterprise resource planning (ERP) solutions. As a leading brand in the domestic pharmaceutical distribution sector, H.Extract's Cloud ERP System, Romens, has established a significant presence, serving over 40,000 pharmacies across China. The company has formed strategic partnerships, notably with Tencent Cloud and WeChat Pay, to enhance the efficiency of the medicine distribution industry, particularly in pharmaceutical wholesale and chain drugstores. With 14 years of experience, H.Extract has developed a strong technical foundation and management expertise in the operation of chain drugstores, allowing it to expand its customer base to include major pharmaceutical entities such as Harbin Pharmaceutical Group and Sichuan Derentang.

Meike Solar is a manufacturer specializing in the research and development of solar photovoltaic polycrystalline silicon wafers. The company employs integrated monitoring systems and equipment to enhance its manufacturing processes, allowing for efficient production at reduced costs. By focusing on advanced technologies and intelligent manufacturing, Meike Solar aims to contribute to the solar energy sector while optimizing operational efficiency.

JOINN Biologics is a California Bay Area-based company specializing in contract development and manufacturing services for biologics and advanced therapies. With over 20 years of experience in supporting drug discovery and development, JOINN offers a comprehensive range of services that includes molecular assessment, clinical trial material production, commercial-scale manufacturing, and both upstream and downstream process development. The company is dedicated to delivering high-quality biologics, aiming to enhance the efficiency of drug development while meeting the needs of patients and the biotech industry. By providing expertise in areas such as analytical and formulation development and regulatory support, JOINN Biologics plays a critical role in facilitating the advancement of biopharmaceutical products on a global scale.

PAQ Therapeutics is a biotechnology company focused on innovating health restoration and disease treatment through the process of autophagy, which is the body's natural mechanism for cellular degradation. The company is developing a unique class of small-molecule degraders utilizing autophagosome-tethering compound technology. This approach allows for the binding of various substrates to the autophagy pathway, thereby enabling the creation of targeted therapies. By harnessing this mechanism, PAQ Therapeutics aims to provide solutions for serious diseases that currently have limited therapeutic options available to patients.

Xianghuanji is a marketing company that specializes in providing an online platform for cell phone rental services. The company operates under a subscription business model, allowing clients to conveniently rent mobile phones through a unified platform. This service caters to individuals and businesses seeking flexible and accessible mobile phone solutions without the commitment of purchasing devices outright.

Chengdu Qitan Technology Co., Ltd. specializes in the development and manufacture of advanced gene sequencing instruments utilizing nanopore technology. Founded in 2016 and based in Chengdu, China, the company offers a fourth generation gene sequencer that enables single-molecule sequencing with long read lengths and real-time output. This innovative technology is designed to serve various sectors, including biopharmaceuticals, healthcare, and agriculture, facilitating applications such as immunophenotyping, pathogen detection, analysis of intestinal flora, and tumor genome detection. Qitan Tech's solutions are notable for their cost-effectiveness and simplicity, as they do not require complicated library preparation, thus enhancing the accessibility of gene sequencing for cutting-edge biological research and clinical diagnostics.

Duality Biologics, founded in January 2020 by Dr. John Zhu, is a biopharmaceutical company focused on developing innovative therapies for oncology and autoimmune diseases. The company is dedicated to addressing unmet medical needs by creating novel modality drugs. Its internal pipeline includes nearly ten promising bispecific antibodies and Antibody-Drug Conjugates (ADCs), with several candidates currently in the Investigational New Drug (IND) stage. Duality Bio has established a next-generation ADC platform, supported by global intellectual property rights, which has been validated through various drug candidates under development. Through its efforts, Duality Biologics aims to enhance treatment options for patients suffering from cancer and autoimmune disorders.

Zhongke Jiuyuan focuses on the manufacturing and sales of key materials such as polyimide films and slurries.

Reliable Med is a medical device developer focused on creating and providing clinical mass spectrometry equipment for in vitro diagnostic (IVD) tests. The company addresses a significant need in the medical industry by offering high-end clinical mass spectrometry solutions and IVD detection kits. By enhancing diagnostic capabilities, Reliable Med aims to enable healthcare professionals to diagnose patients more efficiently and accurately.

EdiGene Inc. is a biotechnology company specializing in the development of genome editing technologies for therapeutic applications in cancer and various genetic diseases. Founded in 2015 and headquartered in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts, EdiGene focuses on both ex vivo and in vivo gene-editing therapies. The company has established proprietary platforms for editing hematopoietic stem cells and T cells, as well as an RNA base editing approach for in vivo applications. EdiGene's innovative methods enable targeted modifications of genetic information in human cells and facilitate high-throughput drug discovery through advanced screening techniques. By translating these technologies into novel therapeutics, EdiGene aims to improve the safety and efficacy of gene therapy, ultimately benefiting patients, the pharmaceutical industry, and the scientific research community.

Synaptic Medical Inc. is a medical device company dedicated to developing and commercializing innovative products aimed at treating cardiac arrhythmias and other cardiovascular diseases. Established in 2005 and headquartered in St. Paul, Minnesota, the company also maintains an office in Beijing, China. Synaptic Medical specializes in cardiac electrophysiology, offering a range of products including bipolar pacing systems, fixed curve and deflectable diagnostic catheters, pulmonary vein mapping catheters, and ablation devices. The company's focus is on creating unique, cost-effective, and clinically advanced technologies that enhance treatment options for physicians and their patients.

Shanghai ANE Logistics Co., Ltd. is a logistics company based in Hangzhou, China, founded in 2010. It specializes in less than truckload (LTL) transportation and has pioneered the franchise model within China's LTL industry. The company operates a comprehensive national delivery network that includes approximately 5,000 franchised stores, self-operated sorting centers, and contracted line-haul trucks. With 50 distribution centers, Shanghai ANE Logistics provides efficient trucking and logistics services, ensuring effective delivery solutions across the country.

Innolake Biopharm is a clinical-stage biotechnology company specializing in the development of therapeutic drugs for oncology and autoimmune diseases. The company focuses on overcoming challenges associated with tumors and immune system disorders through innovative research and development. With an extensive product development pipeline, Innolake Biopharm aims to enhance treatment options for patients, improving their health outcomes and overall quality of life.

Gene+ operates in the biotechnology industry, focusing on genetic research and development. The company offers a range of services including gene panel development and mutation detection in peripheral blood. Gene+ also provides Next Generation Sequencing (NGS) services, contributing to the field of oncology. Their Smart Laboratory, known as Gene+sLab, is another key aspect of their operations. The company is also involved in tumor gene detection, offering precision medicine series, tumor whole process monitoring, and early tumor screening and diagnosis services.

GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. The company utilizes high-throughput sequencing technology combined with intelligent algorithm analysis to address challenges associated with traditional diagnostic methods, such as low detection rates, lengthy processes, and accuracy issues. By improving the timeliness and precision of pathogen diagnosis, GensKey enables patients suffering from severe infections to receive prompt and reliable diagnoses, thereby enhancing the potential for effective treatment and recovery.

EdiGene Inc. is a biotechnology company specializing in the development of genome editing technologies for therapeutic applications in cancer and various genetic diseases. Founded in 2015 and headquartered in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts, EdiGene focuses on both ex vivo and in vivo gene-editing therapies. The company has established proprietary platforms for editing hematopoietic stem cells and T cells, as well as an RNA base editing approach for in vivo applications. EdiGene's innovative methods enable targeted modifications of genetic information in human cells and facilitate high-throughput drug discovery through advanced screening techniques. By translating these technologies into novel therapeutics, EdiGene aims to improve the safety and efficacy of gene therapy, ultimately benefiting patients, the pharmaceutical industry, and the scientific research community.

Kafang is a prominent provider of electronic trading solutions in the Chinese capital market, specializing in advanced quantitative trading methodologies and transaction systems tailored for financial services. The company develops sophisticated algorithmic models that facilitate automated and complex dark pool trading, catering to institutional clients such as pension funds, investment banks, mutual funds, and hedge funds. By focusing on efficiency and reliability, Kafang delivers robust quantitative transaction solutions that enhance trading execution for its clients, positioning itself as a leader in the industry.

Singlomics is a biotechnology company that leverages single-cell sequencing technology to develop innovative antibody drugs aimed at treating infectious diseases and cancers. The company focuses on the discovery and development of neutralizing antibodies, including DXP593 and DXP604, which serve as potential therapeutic solutions against COVID-19. By utilizing advanced sequencing techniques, Singlomics aims to enhance the efficacy of antibody treatments and address significant health challenges in infectious diseases and oncology.

MicuRx Pharmaceuticals is a biopharmaceutical company focused on discovering and developing novel antibiotics to combat drug-resistant bacterial infections. Founded in 2007 and based in Palo Alto, California, MicuRx operates with research and development facilities in both San Francisco, California, and Shanghai, China. The company's portfolio includes MRX-I, an oral antibiotic effective against multi-drug resistant gram-positive pathogens such as methicillin-resistant staphylococcus aureus and vancomycin-resistant enterococci; MRX-IV, a water-soluble prodrug form of MRX-I for intravenous use; MRX-V, an injectable antibiotic targeting gram-negative bacteria; and MRX-VIII, a polymyxin for gram-negative infections. Additionally, MicuRx's pipeline includes other antibacterial drugs designed to combat both gram-positive and gram-negative bacterial pathogens. The company employs a hybrid U.S./China business model, leveraging U.S. research and development with cost-efficient scientific resources in China. Shanghai MicuRx commercializes the agent contezolid in China, while global clinical studies are ongoing.

AccuMedical is a full-line product company in the field of neurological intervention, headquartered in Beijing with an R&D center located in California. It develops and produces medical device products for the treatment of aneurysms, preventing, and treating bleeding diseases caused by the rupture of vascular aneurysms.

Shukun Technology is a Chinese healthcare company founded in 2017 and headquartered in Beijing. It specializes in developing diagnostic systems that leverage machine learning and artificial intelligence to detect cardiovascular diseases and tumors. By employing deep learning algorithms, Shukun Technology intelligently analyzes medical images to automatically identify lesions and generate comprehensive reports. The company's innovations aim to enhance the efficiency of medical professionals, ultimately improving the quality of diagnosis and treatment in primary healthcare settings.

Immvira, established in Shenzhen, China, in May 2015, is a biotechnology company focused on developing innovative immunotherapy solutions for cancer treatment. Founded by a team of renowned researchers, including Professors from prestigious institutions, Immvira specializes in biopharmaceutical technology centered on oncolytic viruses and vector-based methods. The company’s flagship product is a genetically engineered Oncolytic Herpes Simplex Virus, designed to target metastatic tumors and those that are difficult to reach through traditional injection methods. By leveraging its advanced biotechnology platform, Immvira aims to improve treatment outcomes for cancer patients, providing effective therapeutic options for challenging tumor types.

Galaxis technology group, founded in 2014, is a high-tech enterprise focusing on providing integrated logistics automation and robotics solutions and one-stop service. It brings together first-class technical experts and teams from home and abroad. With years of experience in logistics and technical accumulation, has more than hundreds of software copyright, and the national patent, formed the consulting including logistics system planning, software development, system integration, operation guidance, and multi-layer shuttle, high speed lift, AGV, sorting system such as the core research and development of high-end equipment manufacturing as a whole solution, the construction of logistics system can provide customers with one-stop service. High standards, refined product and service quality have kept the company in a leading position in the industry.The application cases are widely applied in more than 10 industries, such as medicine, e-commerce, clothing, books, rail,transit, automobile, etc., and more than 150 large and medium-sized modern logistics centers and production three-dimensional warehouses have been constructed, with the total investment of the project exceeding 20 billion rmb. Headquartered in Jiaxing, the group has technology r&d centers in Germany and Austria, subsidiaries or factories in eight cities of Shanghai, Beijing, Guangzhou, Wuhan, Jiaxing, Wuxi, Chengdu and Kunming. Their vision is to become the world's leading supplier of logistics robots and high-end equipment, technical service providers and system integrators. Focus on customers, continuous innovation, let the world do not hard logistics!

Quantinfo Technology is a Shanghai-based company, established in 2014, that specializes in providing financial information and technology solutions tailored for capital markets. The firm offers a range of products, including FinOne Backtesting and FinOne Quant Trading, which facilitate the development and execution of quantitative trading strategies. These tools encompass features such as historical market data management, algorithm backtesting, data source aggregation, and risk management. Quantinfo Technology serves various financial sectors, including income, Forex, and precious metals, with a clientele that includes notable institutions like ICBC, Bank of Ningbo, and CITIC Securities. By delivering comprehensive quantitative trading support, the company aids financial institutions in optimizing their trading strategies and operations.

Tcpjw offers invoicing supply chain platforms in China. Using big data, cloud and fintech innovation, Tcpjw creates a transparent online trading platform for enterprises to manage efficiency.

Alebund Pharmaceuticals is a biopharmaceutical company specializing in the discovery and development of innovative therapies for renal diseases and associated chronic conditions. The company focuses on researching and commercializing treatments for a variety of kidney-related ailments, including chronic kidney disease, dialysis complications, nephropathy, diabetic kidney disease, and autosomal dominant polycystic kidney disease. With a diversified pipeline of drug candidates, Alebund Pharmaceuticals aims to deliver comprehensive, high-quality solutions to patients suffering from renal diseases, addressing both immediate and long-term healthcare needs in this critical area.

Chifang Information Technology specializes in intelligent investment and trading platforms.

Kafang is a prominent provider of electronic trading solutions in the Chinese capital market, specializing in advanced quantitative trading methodologies and transaction systems tailored for financial services. The company develops sophisticated algorithmic models that facilitate automated and complex dark pool trading, catering to institutional clients such as pension funds, investment banks, mutual funds, and hedge funds. By focusing on efficiency and reliability, Kafang delivers robust quantitative transaction solutions that enhance trading execution for its clients, positioning itself as a leader in the industry.

JOINN Biologics is a California Bay Area-based company specializing in contract development and manufacturing services for biologics and advanced therapies. With over 20 years of experience in supporting drug discovery and development, JOINN offers a comprehensive range of services that includes molecular assessment, clinical trial material production, commercial-scale manufacturing, and both upstream and downstream process development. The company is dedicated to delivering high-quality biologics, aiming to enhance the efficiency of drug development while meeting the needs of patients and the biotech industry. By providing expertise in areas such as analytical and formulation development and regulatory support, JOINN Biologics plays a critical role in facilitating the advancement of biopharmaceutical products on a global scale.

Yijiaoyoupei is a teacher learning platform, dedicated to helping the teacher group complete professional training, so that each teacher can easily improve their professional level; there are many training topics in the platform. The workshop is equipped with various learning resources. Users only need to select the corresponding topics according to their needs to start the training.

Genome Wisdom is a precision medical technology service provider specializing in gene-based solutions for clinical and personal genomics. The company offers high-throughput, high-precision genomic data services, utilizing artificial intelligence and big data technologies to analyze disease molecular mechanisms and oncology treatment dynamics. Through multi-omics integration analysis, Genome Wisdom supports bio-marker discovery based on genetic and pathological data, ultimately aiming to enhance clinical efficiency. Additionally, the company engages in the design, implementation, and industrial incubation of scientific research projects, focusing on molecular pathology analysis in tumor surveillance and related areas.

iSoftStone is China's leading smart city technology service and operator. Focus on the use of emerging technologies such as big data, cloud computing, Internet of Things, artificial intelligence, etc., based on urban development needs, precipitating urban data, providing integrated design, construction and operation services for digital and intelligent cities in China.

Life Real, founded in September 2011, specializes in the development and production of life sciences and clinical diagnostic products. The company offers a range of equipment, including autoclavable pipettes, pipette controllers, micro UV spectrophotometers, and homogenizers, designed to facilitate safe and efficient laboratory experiments. Committed to meeting the scientific research needs of the life sciences sector, Life Real focuses on delivering cost-effective and high-quality diagnostic solutions. The company is actively pursuing product certification and adheres to international standards, ensuring that its products are RoHS compliant and CE certified. Additionally, Life Real is open to OEM and ODM collaborations to meet specific customer requirements, positioning itself as a reliable partner for both domestic and international clients in the scientific community.

Zuodashi is a company specializing in the research and development, production, and sales of food and compound seasonings. It focuses on creating a range of condiments designed to enhance the flavor of takeaway food, catering to diverse culinary needs. In addition to its condiment offerings, Zuodashi has developed software aimed at helping restaurants manage takeaway applications efficiently on a single platform. This combination of product and technology positions the company as a valuable partner for the food service industry.

OnVideo is a developer of a cloud video creation platform that enables users to produce professional-grade videos online. The platform offers a range of video editing software in three versions: free, basic, and premium, catering to different user preferences and needs. This flexibility allows individuals and organizations to customize their video content independently, making it accessible for anyone to create high-quality movies.

MGI Tech is a company that specializes in the development of sequencing devices and multi-omics platforms, including genetic sequencing, medical imaging, and laboratory automation. By producing high-throughput gene sequencers and associated consumables and reagents, MGI Tech supports advancements in life science research and healthcare. The company aims to provide effective and affordable healthcare solutions, facilitating real-time and comprehensive systems for precision medicine and related fields. Its mission focuses on enhancing life science tools and fostering innovation in digital health, contributing to improved healthcare outcomes.

GeneQuantum Healthcare (Suzhou) Co., Ltd. is a high-tech company established in August 2013 in Suzhou Industrial Park, specializing in the research and development of innovative biotherapeutics. The company has developed a world-class bioconjugation technology platform that emphasizes the creation of next-generation anti-tumor Antibody-Drug-Conjugates (ADCs) with significant therapeutic potential. Utilizing a ligase-dependent conjugation platform, GeneQuantum enhances the therapeutic window for these drugs, allowing for advanced development in the field of oncology. The company is currently focused on advancing its ADC candidates toward Investigational New Drug (IND) filing in both the United States and China, while also expanding its product pipeline to address unmet medical needs in cancer treatment.

Hunan Kexin Health Industry Development Co., Ltd. is a healthcare organization based in Changsha, China, established in 2014. The company operates as a three-stage oncology hospital group, focusing on cancer-related services. Kexin Health provides a comprehensive range of offerings, including tumor screening, diagnosis, treatment, and rehabilitation. It aims to develop a chain of oncology hospitals that blend modern medical technologies with traditional Chinese medicine, emphasizing the integration of clinical practice, education, and scientific research in the field of oncology.

Xiaoyu Link is an online video conference solution provider. Xiaoyu Link plans to use the proceeds to enhance its sales and marketing efforts, as well as carrying out research in new products and technologies.

Zhiteng Education specializes in the development and training of extracurricular programs aimed at enhancing the potential of primary school students aged 4 to 12. The company focuses on creating innovative educational courses that support children's cognitive skills, memory, and creativity. Through extensive research in characteristic education, Zhiteng Education has designed specialized training programs that involve both students and their parents, improving overall developmental outcomes. By employing advanced educational theories and cutting-edge teaching models, Zhiteng Education aims to stand out in the industry, fostering profound and wise learning experiences for tens of thousands of students.

Shukun Technology is a Chinese healthcare company founded in 2017 and headquartered in Beijing. It specializes in developing diagnostic systems that leverage machine learning and artificial intelligence to detect cardiovascular diseases and tumors. By employing deep learning algorithms, Shukun Technology intelligently analyzes medical images to automatically identify lesions and generate comprehensive reports. The company's innovations aim to enhance the efficiency of medical professionals, ultimately improving the quality of diagnosis and treatment in primary healthcare settings.

Haihe Biopharma is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative anti-tumor drugs aimed at addressing complex diseases. The company specializes in pharmacological efficacy evaluation and offers a range of products, including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors. Through its research and development efforts, Haihe Biopharma seeks to enhance health outcomes and the quality of research for its customers, providing effective solutions in the fight against cancer.

Aidong Super AI is an industrial Internet services company that specializes in leveraging artificial intelligence technology to enhance operational efficiency and security in various industries. The company offers a range of products and solutions focused on equipment management, fine operation, and industrial security. Their key offerings include systems for improving vehicle efficiency, AI-powered sanitation monitoring, and gait identification technologies. Aidong Super AI aims to elevate the management standards of industrial equipment, such as forklifts, by achieving digitization and transparency in fleet operations.

EdiGene Inc. is a biotechnology company specializing in the development of genome editing technologies for therapeutic applications in cancer and various genetic diseases. Founded in 2015 and headquartered in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts, EdiGene focuses on both ex vivo and in vivo gene-editing therapies. The company has established proprietary platforms for editing hematopoietic stem cells and T cells, as well as an RNA base editing approach for in vivo applications. EdiGene's innovative methods enable targeted modifications of genetic information in human cells and facilitate high-throughput drug discovery through advanced screening techniques. By translating these technologies into novel therapeutics, EdiGene aims to improve the safety and efficacy of gene therapy, ultimately benefiting patients, the pharmaceutical industry, and the scientific research community.

Ruizhi Hechuang Technology is a big data integration service provider. Ruizhi Hechuang Technology designs big data analysis and application technology, carries out key technological breakthroughs in industries, formulates important technical standards, and gathers and trains technological talents urgently needed by the industry. The company provides significant value, high intelligence, and the latest digital solutions to help financial institutions digitally change.

Songxiaocai is a mobile Internet platform that facilitates the trading of agricultural products through an online B2B marketplace. It provides a range of services, including vegetable picking, distribution, and after-sales support, specifically tailored for small and medium-sized retailers. By offering comprehensive solutions that encompass information retrieval, purchasing, and efficient distribution, Songxiaocai enables farmers, wholesalers, and retailers to conduct their business operations more effectively.

Shukun Technology is a Chinese healthcare company founded in 2017 and headquartered in Beijing. It specializes in developing diagnostic systems that leverage machine learning and artificial intelligence to detect cardiovascular diseases and tumors. By employing deep learning algorithms, Shukun Technology intelligently analyzes medical images to automatically identify lesions and generate comprehensive reports. The company's innovations aim to enhance the efficiency of medical professionals, ultimately improving the quality of diagnosis and treatment in primary healthcare settings.

Karaku is a Gaming Platform.

Kalaku is an indoor entertainment, new retail and marketing interaction services company.

Xianlepin is a purchase retail platform.

Bairong is an independent technology platform based in China that specializes in providing financial information services to large companies. Utilizing artificial intelligence, cloud computing, and blockchain technology, Bairong aims to innovate and digitally transform the financial services industry. The company focuses on exploring various scenarios and applications of these advanced technologies, enabling financial institutions to enhance their operations and promote financial inclusion. Through its AI-powered solutions, Bairong supports financial institutions in navigating the complexities of the modern financial landscape.

13 Month Culture Communication is a music production and services company that specializes in various aspects of the music industry. It offers a range of services including music production, music creation, artist management, and the operation of music festivals. By focusing on the incubation and cultivation of new music artists, the company plays a vital role in coordinating music events and fostering talent within the industry. Through its diverse offerings, 13 Month Culture aims to enhance the music experience for both artists and audiences alike.

Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment, and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.

IPao is an internet car rescue platform. They provide small road assistance businesses and provide services such as towing, tire changes, battery charging, and more, enabling users to call for road assistance.

Louxiaoyi offers courier distribution services that incorporate office buildings. They solve the problem of sending and receiving express delivery in office buildings through a combination of online and offline methods. They use the WeChat light application to realize the user's express delivery notification, self-service, and various value-added services.

Nine strong biological is an in-vitro diagnostic reagent and biochemical detection instrument developer, specializing in the development and production of in vitro diagnostic products, its products include small, dense low-density lipoprotein cholesterol, fibronectin, retinol binding protein.

Yiwai publishes articles and videos introducing art to the public.

Cool College is a SaaS enterprise intelligent & digital management learning platform for corporate and employee training services.

Beijing Rogrand Electronic Commerce Co., Ltd. is a private company established in 2012, specializing in medical e-commerce integrated services in China. The firm operates as a comprehensive service platform that encompasses the entire pharmaceutical industry chain, facilitating connections among pharmaceutical companies, pharmacies, clinics, and medical institutions. Rogrand aims to innovate within the pharmaceutical sector by providing a circulation platform that enhances the efficiency and effectiveness of medical commerce, ultimately contributing to the overall advancement of healthcare services in the region.

Founded in 2001, SWS Medical specializes in the research, development, manufacturing, and distribution of blood purification equipment and consumables. The company operates through four segments: blood purification equipment, blood purification consumables, Advanced Hemodialysis Management System, and chain dialysis centers. Its portfolio includes hemodialysis machines, dialyzers, and related accessories. SWS Medical focuses on delivering comprehensive medical solutions for patients with chronic kidney disease (CKD), prioritizing patient welfare and safety. The company holds numerous patents and has established national-level technology research centers, demonstrating its commitment to innovation in the blood purification sector. With a strong presence in China and exports to over 80 countries, SWS Medical is recognized as a reliable partner by top-tier hospitals worldwide.

No Panda Culture (Bukongwenhua) is a Shanghai-based entertainment and culture agency.

Suzhou Lonwin Medical Systems is a manufacturer of medical imaging equipment focused on enhancing the affordability and effectiveness of medical diagnostics and treatment. The company offers a diverse range of products, including magnetic resonance imaging systems, computed tomography systems, and direct digital X-ray imaging systems. Lonwin's product line spans four key areas: magnetic resonance imaging, radiography, imaging-related products, and interventional therapy-related products. By providing powerful imaging solutions, Lonwin enables healthcare practitioners to deliver high-quality, efficient, and cost-effective medical imaging services to hospitals and their patients.

SinoVision is a medical device manufacturing company based in China, established in 2012. It specializes in the development of computed tomography (CT) scanners, offering a range of products including 16-Slice, 32-Slice, and 64-Slice CT scanners. The company also provides advanced technologies such as the sROBOT robot CT navigation system and sAI intelligent imaging solutions. SinoVision holds intellectual property for CT detectors and designs X-ray tubes and high-voltage power supplies specifically for CT scanners. Additionally, it operates a cloud diagnosis platform that integrates CT image post-processing workstations with an online consultation platform, facilitating comprehensive imaging diagnoses for healthcare professionals and institutions.